glp 1 diabete GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes GLP-1/GLP-1R: The Star Target for

10.1089/acm.2006.12.881 Summary Keywords vitamin B12, efficacy, bioavailability, therapeutic approaches, meta-analysis, cobalamin Citation Mazur M, Ndokaj A, Salerno C, Vallone J, Ardan R, Bietolini S, Carrouel F, Wilk A, Sarig R, Ottolenghi L and Bourgeois D (2025) Efficacy of sublingual and oral vitamin B12 versus intramuscular administration: insights from a systematic review and meta-analysis

Guess who was in it

In Phase 3 trials, retatrutide helped patients with Type 2 diabetes lose up to 16.8% of their body weight over 40 weeks, while also significantly improving blood sugar levels

Glucagon-like peptide-1 (GLP-1) receptor (GLP-1R) agonists (GLP-1RAs) are agents that lower blood glucose in type 2 diabetes by stimulating insulin secretion and suppressing glucagon release [28]

Ferroptosis-modulating small molecules for targeting drug-resistant cancer: challenges and opportunities in manipulating redox signaling

If once-daily convenience is required, longer-acting alternatives like modified GRF or CJC-1295 with DAC are more appropriate choices